Sorensen, Cecilia J.
DeSanto, Kristen
Borgelt, Laura
Phillips, Kristina T.
Monte, Andrew A.
Funding for this research was provided by:
National Institutes of Health (1 K23 GM110516, CTSI UL1 TR001082)
National Institute on Drug Abuse (R15 DA041656, R01 DA034957)
University of Colorado (US), Skaggs School of Pharmacy and Pharmaceutical Sciences
Colorado Department of Public Health and Environment
Article History
Received: 26 September 2016
Revised: 25 November 2016
Accepted: 1 December 2016
First Online: 20 December 2016
Compliance with Ethical Standards
:
: Dr. Sorensen has no conflicts of interest to declare. Kristen DeSanto has no conflicts of interest to declare. Dr. Borgelt receives support from the Colorado Department of Public Health and Environment and the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Phillips receives support from NIH on Drug Abuse R15 DA041656 and R01 DA034957, and Dr. Monte receives support from NIH 1 K23 GM110516 and NIH CTSI UL1 TR001082.